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Yellow nail syndrome is a rare disease of unclear etiology. We describe a patient who develops yellow
nail syndrome, with primary nail and sinus manifestations, shortly after amalgam dental implants. A
study of the patient's nail shedding showed elevated nail titanium levels. The patient had her dental
implants removed and had complete resolution of her sinus symptoms with no change in her nail
ﬁndings. Since the patient's nail ﬁndings did not resolve we do not believe titanium exposure is a cause
of her yellow nail syndrome but perhaps a possible relationship exists between titanium exposure and
yellow nail syndrome that requires further studies.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).To the Editor,
Yellow nail syndrome (YNS) is a rare disorder characterized by a
triad of yellow nails, lymphedema, and respiratory manifestations
including chronic sinusitis, bronchiectasis, or pleural effusions [1].
The pathogenesis of the disease has not been elucidated, however,
there have been reports suggesting an association between tita-
nium exposure and YNS.
We observed a 56-year-old Caucasian female who presented
with a two-year history of chronic sinusitis and cough that had
been resistant to standardmedical therapy. During these two years,
the patient had an extensive work-up that was unrevealing for an
inciting cause, including normal chest computed tomography scans
with no evidence of bronchiectasis or pleural effusions. However,
the patient's clinical examination revealed thick yellow nails
(Fig. 1). The culmination of chronic sinusitis and yellow nails led to
the diagnosis of YNS. Further inquiry revealed that her symptoms
and nail changes started within a year of receiving amalgam dental
implants.
Amalgam implants and ﬁllings used in dental work contain aLtd. This is an open access article ucombination of metal alloys, including titanium (Ti), that are sus-
ceptible to galvanic chemical corrosion. This complex phenomenon
occurs when two different metals, at the same or distant location,
interact through a potential difference. The titanium dioxide (TiO2)
is oxidized into titanium ions (Ti2þ), which is absorbed and
distributed throughout the circulation into various tissue beds,
including the liver, spleen, lung, and peritoneal tissue, with the
exception of the heart and kidneys [2].
Titanium dioxide is also a common excipient used as a coating
agent, whitener and opaciﬁer in many medications including cap-
sules, suspensions, tablets, and topical preparations [2]. It is un-
likely that a standardized amount is used in the formulation of
capsules or tablets since it is a ubiquitous substance. Despite the
widespread use in the food and pharmaceutical industry, there is
very limited information on the absorption, distribution, and
toxicity of titanium in humans.
Recent papers evaluated the possibility of titanium exposure, via
implants or medications, as a cause of yellow nail syndrome
through an analysis of nail clippings in patients who have received
dental amalgams and knee titanium implants [3e5].
Upon recognizing the patient's amalgam dental implants as a
potential etiology for her YNS, a complete nail shedding was sent
for analysis. Inductively coupled plasma sector ﬁeld mass spec-
trometry and inductively coupled plasma atomic emission spec-
trophotometry were used to analyze the composition of the nailnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Findings of thick, discolored yellow nails on examination.
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(normal value 0 mcg/g). Given this ﬁnding the patient had her
implants removed and within a year was observed to have
complete resolution of her sinusitis symptoms but without
change in her nail ﬁndings.
While the presence of titanium in the nails alone does not
establish a cause and effect relationship with YNS, we believe that
further studies in this ﬁeld are warranted. It is possible that speciﬁc
patients may have an underlying genetic or immunological dispo-
sition to develop YNS when exposed to titanium. Further studies
are needed in this ﬁeld. Although, the rarity of YNS and the difﬁ-
culty of obtaining nail titanium levels are limiting factors. We
recommend a thorough evaluation of potential titanium exposures,
including implants and medications, in this population and
removing the patient's source, if feasible, to determine a casual
relationship.
It remains unclear to the authors why the patient's sinus
symptoms improved but not her nail ﬁndings. One potential theory
is that the patient has not shed her nails that already contain the
titanium. Normal nails grow at a rate of 3 mm per month, taking an
average of 3e6 months to regrow completely. In YNS nail growth is
halted or slowed to a rate of less than 0.25 mm per week. We will
continue to follow up with the patient to determine if this theory
holds true.
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